Colombier Acquisition Corp. II (CLBR) is a special purpose acquisition company (SPAC) dedicated to merging with innovative, high-growth enterprises primarily in the technology and healthcare sectors. Leveraging the extensive experience of its seasoned management team and robust strategic network, CLBR is well-equipped to identify and capitalize on transformative investment opportunities that reflect current market dynamics. The company's mission is to deliver substantial shareholder value through strategic acquisitions that foster operational synergies and scalable growth, positioning it as a compelling investment choice in a rapidly evolving landscape.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -0.87% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.36 |
| Price-to-Book | 2.13 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 229.10% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $17.25M |
| Float | $11.84M |
| % Insiders | 0.00% |
| % Institutions | 85.59% |
Volatility is currently expanding